Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cancer Research|December 15, 1990
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunityB Gansbacher, R Bannerji, B Daniels, et al.
The Journal of Experimental Medicine|October 1, 1990
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunityB Gansbacher, K Zier, B Daniels, et al.
Blood|March 1, 1994
Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAsF M Rosenthal, K Cronin, R Bannerji, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1993
Tumor-bearing animals contain suppressed antitumor effectors the function of which can be unmasked by IL-2S Salvadori, F M Rosenthal, K Cronin, et al.
Natural Immunity|March 1, 1994
Cytokine gene therapy: a new strategy for the management of cancer patientsR Foa, A Guarini, A Cignetti, et al.
Cancer Research|January 1, 1991
Expression of functional epidermal growth factor receptors in a human hematopoietic cell lineJ Oval, R Hershberg, B Gansbacher, et al.
Journal of the National Cancer Institute|April 7, 1993
Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblastsS C Tsai, B Gansbacher, L Tait, et al.
International Journal of Cancer|February 1, 1993
Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cellsA Porgador, B Gansbacher, R Bannerji, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cellsT Alosco, B A Croy, B Gansbacher, et al.
International Journal of Cancer|April 10, 1995
Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejectionI Hara, H Nguyen, Y Takechi, et al.
Pageof 6